← Leaderboards
Martin J Cannon
University Of Arkansas Med Scis Ltl Rock
$2,395,650
Attributed
$4,210,123
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $916.9K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,210,123 · 4
By mechanism
U01$2,721,709 · 1
R01$1,028,226 · 1
R21$393,402 · 1
R41$66,786 · 1
Top collaborators
- Rupak Pathak4 shared
- Jerry Ware4 shared
Most similar at University Of Arkansas Med Scis Ltl Rock
Same institution · by research overlap
- Martin Hauer-Jensen$11,801,523
- Guido J. Tricot$3,260,370
- Nikhil C Munshi$559,098
Others in their field
Top investigators on “Dendritic Cells”
- Barton F Haynes · Duke University$112,608,041
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- James C. Paulson · Scripps Research Institute$41,568,802
- Ulrich H Von Andrian · Harvard Medical School$32,521,007
- Donald L Morton · John Wayne Cancer Institute$29,042,629
Research focus
Dendritic CellsIn VivoResponseImmunosuppressionCytokineMouse ModelB-LymphocytesAntibodiesCd4 Positive T LymphocytesVaccinationExhibitsCell PhysiologyAreaAdaptive Immune ResponseCardiovascular DiseasesCellsExperimental ModelsBiologicalBindingAdverse EffectsDoseBone CellBone MarrowAutoimmune Diseases
Grant awards (11)
Platelets in radiation-induced immune dysregulation$693,302
U01 · FY2025 · AI
Mechanisms of Th17-DC immunotherapy for ovarian cancer$178,819
R21 · FY2025 · CA · contact PI
Platelets in radiation-induced immune dysregulation$702,309
U01 · FY2024 · AI
Mechanisms of Th17-DC immunotherapy for ovarian cancer$214,583
R21 · FY2024 · CA · contact PI
Platelets in radiation-induced immune dysregulation$649,094
U01 · FY2023 · AI
Platelets in radiation-induced immune dysregulation$677,004
U01 · FY2022 · AI
Novel target antigens for ovarian cancer immunotherapy$248,413
R01 · FY2007 · CA · contact PI
Novel target antigens for ovarian cancer immunotherapy$255,833
R01 · FY2006 · CA · contact PI
Novel target antigens for ovarian cancer immunotherapy$261,990
R01 · FY2005 · CA
Dendritic cell immunotherapy for ovarian cancer$66,786
R41 · FY2005 · CA
Novel target antigens for ovarian cancer immunotherapy$261,990
R01 · FY2004 · CA